PET MPI STATISTICS
Image Quality
PET Myocardial Perfusion provides excellent spatial resolution and attenuation correction. The enhanced image quality for PET MPI vs. SPECT is due to:
- Higher count rates (240% increase over SPECT)
- Improved spatial resolution
- Routine and robust attenuation correction on all scans
- Images can be sliced at 3mm (PET MPI) instead of 6mm (SPECT) to better detect multi-vessel disease
Diagnostic Accuracy
PET myocardial perfusion has a 95% sensitivity and 95% specificity for detecting coronary artery disease, while SPECT myocardial perfusion has an 87% sensitivity and 73% specificity for detection.
Prognostic Value
Obese patients who are often difficult to image with SPECT had excellent outcomes using PET MPI with Rb-82. The graph on the right has a curve that shows the difference between survival, free from any cardiac events, for patients with a normal vs. an abnormal PET MPI scan. This study also went on to show that for hard cardiac events (cardiac death & MI), patients with a normal PET scan had a 0% annualized event rate, which is quite impressive.
Rubidium-82
Half life is 75 seconds; dose range is 20-60 mCi. Rb-82 has a high myocardial extraction fraction at peak stress flow; tracer uptake is more proportional to myocardial blood flow and facilitates better detection of disease.
Pharmacokinetics
PET MPI uses higher energy tracers 511keV v. 140KeV for SPECT; this leads to higher count rates and improved image quality.
Artifacts
PET MPI offers attenuation correction on all scans, reduces ambiguity, enhances interpretive certainty
Scan Time Efficiency
30 minutes for PET MPI for gated rest/stress v. 2.5-4 hours for SPECT
PET MPI v. SPECT
Characteristics of SPECT vs. PET MPI | ||
PET | SPECT | |
Availability | Limited | Wide |
Attenuation correction | Accurate | Less accurate |
Spatial resolution | 5–7 mm | 12–15 mm |
Protocol | < 1 hour | 2 days |
Radiation | < 10 mSv | > 10 mSv |
Images | Quantitative | Qualitative |
Hybrid with CT | Yes | Yes |
References
– Bateman, TM. Cardiac Positron Emission Tomography and the Role of Adenosine Pharmacalogic Stress. American Journal of Cardiology. 2004; 94:19-24.
– Bateman, TM, Heller, GV, McGhie, IA, et. al. Diagnostic Accuracy of Rest/Stress ECG-gated Rb-82 Myocardial Perfusion PET: Comparison with ECG-gated Tc-99m Sestamibi SPECT. Journal of Nuclear Cardiology. 2006;13:24-33.
– Chow BJ, Wong JW, Yoshinaga K, et. al. Prognostic Significance of Dipyridamole-Induced ST Depression in Patients with Normal 82Rb PET Myocardial Perfusion Imaging. J Nucl Med. 2005;46:1095-1101.
– Dilsizian, V. Atlas of Nuclear Cardiology. 2003.
– Gould, KL. Reversal of Coronary Atherosclerosis: Clinical Promise as the Basis for Non-invasive Management of Coronary Artery Disease. Circulation. 1994;90:1558-1571.
– Medical Imaging & Technology Alliance
– Merhige ME, Breen WJ, Shelton V, et al. Impact of myocardial perfusion imaging with PET and (82)Rb on downstream invasive procedure utilization, costs, and outcomes in coronary disease management. J Nucl Med. 2007;48:1069-1076.
– Yoshinaga, K, Chow, BW, Williams, K, et. al. What is the Prognostic Value of Myocardial Perfusion Imaging Using Rubidium-82 Positron Emission Tomography? JACC. 2006; 48:1029-39.